Evidence map›Paper›PMID 41048514›Full record

ArticleFrontiers in microbiology2025

The effect of cCMP and cUMP on growth of

Christoph Risser, Justin Rothschuh, Heike Bähre, Detlef Neumann, Roland Seifert, Bastian Schirmer

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christoph RisserHannover Medical School, Institute of Pharmacology, Hannover, Germany.
Justin RothschuhHannover Medical School, Institute of Pharmacology, Hannover, Germany.
Heike BähreHannover Medical School, Research Core Unit Metabolomics, Hannover, Germany.
Detlef NeumannHannover Medical School, Institute of Pharmacology, Hannover, Germany.
Roland SeifertHannover Medical School, Institute of Pharmacology, Hannover, Germany.
Bastian SchirmerHannover Medical School, Institute of Pharmacology, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to screen for possible biological effects of the non-canonical nucleotides 3',5'-cyclic uridine monophosphate (cUMP) and 3',5'-cyclic cytidine monophosphate (cCMP) on Pseudomonas aeruginosa beyond the already reported function in the bacterial pyrimidine cyclase system for antiphage resistance (Pycsar). Since endogenously synthesized cCMP was detected in growing bacterial cultures and the cCMP concentration was higher when nutrients became more restricted, we hypothesized that a membrane-permeable analog of cCMP added to growing cultures alters growth kinetics. Indeed, when growing in a nutrient-scarce minimum salt medium, the cCMP analog acetoxymethyl-cCMP led to a dose-dependent growth lag, whereas neither its native counterpart nor cAMP, cGMP, or cUMP induced such a lag. This inhibitory effect on growth translated into a sensitizing effect against the antibacterial drugs azithromycin and, very pronounced, against gentamicin. Since

Indexed as

5’-cCMP5’-cUMPbiofilmcyclic nucleotidesPseudomonas aeruginosa

Identifiers

PMID41048514
PMCPMC12489823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.